Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Comment by canadapieton Oct 16, 2023 11:31am
128 Views
Post# 35685407

RE:RE:RE:RE:RE:New Press Release - Theratechnologies Announces Finalization of Amendments to Some of the Terms and Conditions of its Credit Agreement with Marathon

RE:RE:RE:RE:RE:New Press Release - Theratechnologies Announces Finalization of Amendments to Some of the Terms and Conditions of its Credit Agreement with Marathon
Man o man, what you are hoping for is a miracle......!

There is NO STRONG INTEREST! They are saying that for how many years????? 
And they will dilute if they think they have to! There is no insider buying(at such a "ridiculous price" = their words!!!!)  and the insiders holding an important amount of shares is 0.
So, they will dilute so they can earn their paychecq in the future! 

Good luck with your miracle!

Ps: luck and hope are the words the most expressed here for years.....
Ps2: miracles happen sometimes......:-) 
Ps3: for the patients sake, i hope it will happen! 

RE:RE:RE:RE:New Press Release - Theratechnologies Announces Finalization of Amendments to Some of the Terms and Conditions of its Credit Agreement with Marathon
That or they dilute us at around 50 cents for lack of better option or to prevent futur covenant breach.  And that would be the last of those guys for shure. stong interest they mentioned more than once should translate into somekind of deal before long if such interest is real.

2)The stong interest they mentioned more than once should translate into somekind of deal before long if such interest is real.






<< Previous
Bullboard Posts
Next >>